The income is generated through the sale of Karunya Lottery which is exclusively devoted for extending financial assistance to this purpose. Hence this finance is fully contributed by the public. Kerala government buy Talazoparib started free karunya dialysis scheme 6 months ago which provide 2 hemodialysis per week irrespective of the residual renal function. We conducted a study to compare
the surogate markers of dialysis adequacy between patients undergoing hemodialysis in karunya dialysis scheme and in private sector. Methods: This was a cross-sectional observational study. All the 83 patients who were undergoing Hemodialysis under karunya scheme in our institution (Government medical college kerala,
India) and 100 patients undergoing hemodialysis in 3 randomly selected dialysis centers under private sector in our city were enrolled into our study. Patients informations were retrieved from from dialysis unit using a data entry form. The information retrieved included patients demographic data, etiology of ESRD, frequency of hemodialysis, types of vascular access used for hemodialysis, frequency of intravenous iron therapy and ESA and the frequency of blood transfusion. The surrogate markers for adequacy selleck screening library like Hemoglobin, ferritin, Albumin, Calcium, phosphrous PTH, lipid profile, signs of fluid overload, uraemic symptoms and biometrics
like midarm circumference, BMI and triceps skin fold thickness were compared between the 2 groups. We also looked at the quality of life based on WHO-QOL BREF questionaries in both the groups. Statistical analysis was done using SPSS version 4-Aminobutyrate aminotransferase 21.0. Results: There were no statistical difference between the two groups in all the parameters compared. Conclusion: Karunya free Dialysis Scheme is an effective way for improving the access to maintenance hemodialysis and renal care without compromising on the outcome and quality of life. Hence we suggest karunya model of dialysis to all End Stage Renal Disease (ESRD) patients in resouce poor countries. HUNG CHI-CHIH, CHANG JER-MING, TSAI JER-CHIA, CHEN HUNG-CHUN Division of Nephrology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University Introduction: Higher hemodialysis (HD) adequacy presented as Kt/V is associated with lower all-cause mortality in observational studies, though randomized HEMO study showed no superior survival of higher target Kt/V group patients (Kt/V 1.65 vs Kt/V 1.25). Some subgroups of HD patients such as Asian people or female may have benefits under higher Kt/V. Thus, we would ask whether higher Kt/V with the dose more than that in HEMO study would be associated better survival after long term follow-up.